The urology catheters market has seen considerable growth due to a variety of factors.
• The urology catheters industry has seen significant expansion in recent times. The market, which was valued at $3.5 billion in 2024, is projected to increase to $3.78 billion in 2025, with a compound annual growth rate (CAGR) of 8%.
The earlier growth is largely due to fast-ageing population, the escalating incidence of urinary disorders, the need for urinary catheters for post-surgery comfort, increasing UTI risks, and a shift towards self-care by patients.
The urology catheters market is expected to maintain its strong growth trajectory in upcoming years.
• The urology catheters market is projected to experience robust expansion in the coming years, with an expected valuation of $5.07 billion in 2029 and a compound annual growth rate (CAGR) of 7.7%.
This growth during the forecast period can be linked to an increase in urinary tract tumor cases, a rise in BPH-related surgeries, an upswing in bladder cancer occurrences, a favourable reimbursement landscape, and a mounting number of surgical procedures. Key trends for the forecast period encompass technological advancements, the introduction of biodegradable catheters, the launching of new products, the growing adoption of silicone-based catheters, and the integration of the Internet of Things (IoT) into urology devices.
Expectations are that the escalating incidence of bladder cancer will boost the expansion of urology catheter markets in the future. This particular type of cancer, which originates in the bladder's cells - a lower abdominal, hollow, muscular organ for urine storage - is on the increase. Older populations, heightened exposure to carcinogens, pelvic radiation, and inadequate water consumption are all contributors to this rise. Urology catheters, essential for managing urinary flow and drainage in patients with bladder cancer, especially after surgical procedures or treatments that impede normal bladder function. As an example, Cancer Research UK, a charity based in the UK, has forecasted that the average annual number of new bladder cancer cases in the UK will rise from about 9,800 in 2023-2025 to an estimated 10,700 cases per annum by 2038-2040 in July 2024. Thus, the escalating incidence of bladder cancer is a major driver in the growth of the urology catheter market.
The urology catheters market covered in this report is segmented –
1) By Product Type: Intermittent Catheters, Foley Catheters, External Catheters, Other Product Types
2) By Material: Latex, Silicone, Other Materials
3) By Application: Urinary Incontinence, Benign Prostatic Hyperplasia, Surgery, Other Applications
4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings
Subsegments:
1) By Intermittent Catheters: Straight Catheters, Coude Catheters, Hydrophilic Catheters, Reusable Catheters, Disposable Catheters
2) By Foley Catheters: Silicone Foley Catheters, Latex Foley Catheters, Anti-Bacterial Foley Catheters, 2-Way Foley Catheters, 3-Way Foley Catheters
3) By External Catheters: Male External Catheters, Female External Catheters, Condom Catheters
4) By Other Product Types: Urethral Catheters, Suprapubic Catheters, Nephrostomy Catheters, Catheter Accessories
Firms leading the urology catheter market are zeroing in on innovations in technology to create products like intermittent urological catheters, aimed at facilitating occasional bladder emptying while ensuring patient autonomy. Such an intermittent urological catheter is a one-time use device employed to discharge urine from the bladder when a person is unable to do so naturally. Otsuka Pharmaceutical Factory Inc., for example, a medical device corporation based in Japan, unveiled the OT-Balloon Catheter, an intermittent urological catheter, in July 2022. This catheter, intended for repeat self-catheterization, is a solution for those facing difficulties with natural urination. One key feature is its inflatable balloon placed at the end which enables a temporary insertion into the bladder, ensuring secure positioning during sleep or outdoor activities. It negates the necessity for frequent self-catheterization as long as it's being used, offering a convenience factor. The catheter can conveniently fit into a patient’s routine, providing flexibility and simplified management.
Major companies operating in the urology catheters market are include:
• Cardinal Health Inc.
• Medtronic PLC
• Becton Dickinson and Company
• Boston Scientific Corporation
• Medline Industries Inc.
• B. Braun Melsungen AG
• Otsuka Pharmaceutical Factory Inc.
• Coloplast A/S
• Dentsply Sirona Inc.
• Teleflex Incorporated
• Cook Medical
• ConvaTec Group PLC
• Hollister Incorporated
• Amsino International Inc.
• Well Lead Medical Co.Ltd.
• Urocare Products Inc.
• Bactiguard AB
• CURE MEDICAL LLC.
• Degania Silicone Ltd.
• C R Bard Inc.
• ASID BONZ GmbH
• CompactCath Inc.
• Go Medical Industries Pty Ltd.
• UROTECH GmbH
• J and M Urinary Catheters LLC
North America was the largest region in the urology catheters market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urology catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.